Curcumin, traditionally used as food and medicinal purposes, has recently been reported to have protective efficacy against hypoxia. Hypoxia is one of the important reactive factors in tumor metastasis, which is a key problem in clinical thyroid cancer therapy. In present study, we investigate the anti-metastatic effect of curcumin on the K1 papillary thyroid cancer cells as well as its potential mechanisms. The results show that curcumin effectively inhibits hypoxia-induced reactive oxygen species (ROS) upregulation and significantly decreases the mRNA and protein expression levels of hypoxia-inducible factor-1α (HIF-1α) in K1 cells. Curcumin also decreases the DNA binding ability of HIF-1α to hypoxia response element (HRE). Furthermore, curcumin enhances E-cadherin expression, inhibits metalloproteinase-9 (MMP-9) enzyme activity, and weakens K1 cells migration under hypoxic conditions. In summary, these results indicate that curcumin possesses a potent anti-metastatic effect and might be an effective tumoristatic agent for the treatment of aggressive papillary thyroid cancers.
LanttoTAColucciMZávadováVHiltunenRRaasmajaA. Cytotoxicity of curcumin, resveratrol and plant extracts from basil, juniper, laurel and parsley in SH-SY5Y and CV1-P cells. Food Chem2009; 117: 405–11.
2.
ParvathyKSNegiPSSrinivasP. Antioxidant, antimutagenic and antibacterial activities of curcumin-β-diglucoside. Food Chem2009; 115: 265–71.
3.
SongFZhangLYuH-XLuR-RBaoJ-DTanCSunZ. The mechanism underlying proliferation-inhibitory and apoptosis-inducing effects of curcumin on papillary thyroid cancer cells. Food Chem2012; 132: 43–50.
RobieDKDinauerCWTuttleRMWardDTParryRMcClellanDSvecRAdairCFrancisG. The impact of initial surgical management on outcome in young patients with differentiated thyroid cancer. J Pediatr Surg1998; 33: 1134–8; discussion 9–40.
7.
YangCLLiuYYMaYGXueYXLiuDGRenYLiuXBLiYLiZ. Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS ONE2012; 7: e37960–e37960.
8.
MitraAChakrabartiJBanerjiAChatterjeeADasBR. Curcumin, a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells HEp2. J Environ Pathol Toxicol Oncol2006; 25: 679–90.
9.
SemenzaGL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer2003; 3: 721–32.
RajoriaSSurianoRGeorgeAShanmugamASchantzSPGeliebterJTiwariRK. Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer. PLoS ONE2011; 6: e15879–e15879.
12.
ImaiTHoriuchiAWangCOkaKOhiraSNikaidoTKonishiI. Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol2003; 163: 1437–47.
13.
LesterRDJoMMontelVTakimotoSGoniasSL. uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. J Cell Biol2007; 178: 425–36.
14.
AmelioIMelinoG. The “Sharp” blade against HIF-mediated metastasis. Cell Cycle2012; 11: 4530–5.
15.
RachaganiSSenapatiSChakrabortySPonnusamyMPKumarSSmithLMJainMBatraSK. Activated KrasG(1)(2)D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin. Br J Cancer2011; 104: 1038–48.
16.
SowterHMRatcliffePJWatsonPGreenbergAHHarrisAL. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res2001; 61: 6669–73.
17.
DaviesLWelchHG. Thyroid cancer survival in the United States: observational data from 1973 to 2005. Arch Otolaryngol Head Neck Surg2010; 136: 440–4.
18.
LiRWangYLiuYChenQFuWWangHCaiHPengWZhangX. Curcumin inhibits transforming growth factor-beta1-induced EMT via PPARgamma pathway, not Smad pathway in renal tubular epithelial cells. PLoS ONE2013; 8: e58848–e58848.
19.
KallioPJPongratzIGradinKMcGuireJPoellingerL. Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc Natl Acad Sci U S A1997; 94: 5667–72.
20.
EpsteinACGleadleJMMcNeillLAHewitsonKSO'RourkeJMoleDRMukherjiMMetzenEWilsonMIDhandaATianYMMassonNHamiltonDLJaakkolaPBarsteadRHodgkinJMaxwellPHPughCWSchofieldCJRatcliffePJ. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell2001; 107: 43–54.
21.
BaeMKKimSHJeongJWLeeYMKimHSKimSRYunIBaeSKKimKW. Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1. Oncol Rep2006; 15: 1557–62.
22.
WeidemannAKlankeBWagnerMVolkTWillamCWiesenerMSEckardtKUWarneckeC. Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1alpha, is a direct and sufficient stimulus for brain-type natriuretic peptide induction. Biochem J2008; 409: 233–42.
23.
CowinPWelchDR. Breast cancer progression: controversies and consensus in the molecular mechanisms of metastasis and EMT. J Mammary Gland Biol Neoplasia2007; 12: 99–102.
24.
LiJZhouBP. Activation of beta-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters. BMC Cancer2011; 11: 49–49.
25.
Moreno-BuenoGPortilloFCanoA. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene2008; 27: 6958–69.
26.
HuangTChenZFangL. Curcumin inhibits LPS-induced EMT through downregulation of NF-kappaB-Snail signaling in breast cancer cells. Oncol Rep2013; 29: 117–24.
27.
BeavonIR. The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur J Cancer2000; 36: 1607–20.
28.
SahlgrenCGustafssonMVJinSPoellingerLLendahlU. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci U S A2008; 105: 6392–7.
29.
MaxovaHNovotnaJVajnerLTomasovaHVytasekRVizekMBacakovaLValouskovaVEliasovaTHergetJ. In vitro hypoxia increases production of matrix metalloproteinases and tryptase in isolated rat lung mast cells. Physiol Res2008; 57: 903–10.
30.
ChoiJYJangYSMinSYSongJY. overexpression of MMP-9 and HIF-1alpha in breast cancer cells under hypoxic conditions. J Breast Cancer2011; 14: 88–95.
31.
LeeSJLimJHChoiYHKimWJMoonSK. Interleukin-28A triggers wound healing migration of bladder cancer cells via NF-kappaB-mediated MMP-9 expression inducing the MAPK pathway. Cell Signal2012; 24: 1734–42.
32.
BonelloSZahringerCBelAibaRSDjordjevicTHessJMichielsCKietzmannTGorlachA. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol2007; 27: 755–61.
